These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 848920)

  • 1. [Pharmacokinetics of rifampicin in single and repeated administration to patients with inflammatory processes in the lungs of nontuberculotic etiology].
    Makarenkova RV; Kopeiko IP
    Antibiotiki; 1977 Mar; 22(3):259-60. PubMed ID: 848920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental pharmacodynamic study of rifampicin administered by various methods].
    Shapovalov VP; Mil'chenko KP; Kovalenko NN
    Antibiotiki; 1982 Jun; 27(6):434-7. PubMed ID: 7114830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation on the serum and lung tissue level of rifampicin in man.
    Kiss IJ; Faragó E; Juház I; Bacsa S; Fábián E
    Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):42-7. PubMed ID: 1248917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of penicillins in the blood of dogs administered the combination preparation, ampiox, internally].
    Vasil'ev VK
    Antibiotiki; 1976 Nov; 21(11):1000-2. PubMed ID: 1020929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of rifampicin in experimental animals].
    Koroleva VG; Fomina IP
    Antibiotiki; 1976 Aug; 21(8):722-5. PubMed ID: 999253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampicin as an oral angiogenesis inhibitor targeting hepatic cancers.
    Shichiri M; Fukai N; Kono Y; Tanaka Y
    Cancer Res; 2009 Jun; 69(11):4760-8. PubMed ID: 19458074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of oral rifampicin in AIDS patients.
    Jaruratanasirikul S
    J Med Assoc Thai; 1998 Jan; 81(1):25-8. PubMed ID: 9470318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption of rifampicin in gastrectomized patients. Effect of meals.
    Hagelund CH; Wåhlén P; Eidsaunet W
    Scand J Respir Dis; 1977 Oct; 58(5):241-6. PubMed ID: 601547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphogenic introduction into lesser circulation of orally administered rifampicin in standard and liposomal forms].
    Petrenko TI; Ursov IG; Kurunov IuN; Borodin IuI; Sidorova LD
    Probl Tuberk; 1995; (3):53-4. PubMed ID: 7617640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].
    Titarenko OT; Vakhmistrova TI; Perova TL
    Antibiotiki; 1983 Sep; 28(9):698-702. PubMed ID: 6638984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms.
    Agrawal S; Panchagnula R
    Biopharm Drug Dispos; 2005 Nov; 26(8):321-34. PubMed ID: 16059874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of an experimental study of the pharmacokinetics of polymyxin B sulfate].
    Vasil'ev VK; Koroleva VG
    Antibiotiki; 1976 Jul; 21(7):621-4. PubMed ID: 182072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rifampicin in the therapy of gonorrheal urethritis in men].
    Levochkin AM; Skuratovich AA; Kanaichev NI; Shipilova TV
    Antibiotiki; 1976 Mar; 21(3):270-2. PubMed ID: 1275476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of rifampicin.
    Acocella G
    Clin Pharmacokinet; 1978; 3(2):108-27. PubMed ID: 346286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of activated charcoal on rifampicin absorption in man.
    Orisakwe OE; Dioka CE; Okpogba AN; Orish CN; Ofoefule SI
    Tokai J Exp Clin Med; 1996 Feb; 21(1):51-4. PubMed ID: 9239805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and urine concentrations of rifampicin administered by intravenous infusion in man.
    Acocella G; Bonollo L; Mainardi M; Margaroli P; Tenconi LT
    Arzneimittelforschung; 1977; 27(6):1221-6. PubMed ID: 578447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
    Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
    Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of blood concentration of rifampicin between administration before and after breakfast].
    Tsukamura M; Yokouchi J; Miwa T; Koike K
    Kekkaku; 1972 Apr; 47(4):69-73. PubMed ID: 5073928
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations.
    Panchagnula R; Singh I; Kaur KJ; Kaul CL
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):625-8. PubMed ID: 10669909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rifampicin and its clinical use].
    Fafrowicz B
    Wiad Lek; 1971 Jul; 24(3):233-8. PubMed ID: 4926926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.